title: Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.
authors.affiliation: Rheumatology Section, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, 29010 Málaga, Spain. afn@mail.cofaran.es
authors.forename: Antonio
authors.initials: A
authors.lastname: Fernández-Nebro
authors.forename: Eva
authors.initials: E
authors.lastname: Tomero
authors.forename: Vera
authors.initials: V
authors.lastname: Ortiz-Santamaría
authors.forename: María Carmen
authors.initials: MC
authors.lastname: Castro
authors.forename: Alejandro
authors.initials: A
authors.lastname: Olivé
authors.forename: Manuel
authors.initials: M
authors.lastname: de Haro
authors.forename: Rosa García
authors.initials: RG
authors.lastname: Portales
authors.forename: Rosa
authors.initials: R
authors.lastname: García-Vicuña
authors.forename: María Victoria
authors.initials: MV
authors.lastname: González-Mari
authors.forename: Armando
authors.initials: A
authors.lastname: Laffón
authors.forename: Rosario
authors.initials: R
authors.lastname: García-Vicuña
mesh_terms: D000328:Adult; D000368:Aged; D000686:Amyloidosis / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects / Q000627:therapeutic use; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D013030:Spain / Q000453:epidemiology; D013167:Spondylitis, Ankylosing / Q000150:complications / Q000188:drug therapy / Q000401:mortality; D015996:Survival Rate; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068800:Etanercept